169 related articles for article (PubMed ID: 20629080)
1. Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy.
Wang JZ; Mayr NA; Zhang D; Li K; Grecula JC; Montebello JF; Lo SS; Yuh WT
Cancer; 2010 Nov; 116(21):5093-101. PubMed ID: 20629080
[TBL] [Abstract][Full Text] [Related]
2. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging.
Mayr NA; Taoka T; Yuh WT; Denning LM; Zhen WK; Paulino AC; Gaston RC; Sorosky JI; Meeks SL; Walker JL; Mannel RS; Buatti JM
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):14-22. PubMed ID: 11777618
[TBL] [Abstract][Full Text] [Related]
3. Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer.
Mayr NA; Wang JZ; Lo SS; Zhang D; Grecula JC; Lu L; Montebello JF; Fowler JM; Yuh WT
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):719-27. PubMed ID: 19632061
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI.
Nam H; Park W; Huh SJ; Bae DS; Kim BG; Lee JH; Lee JW; Lim DH; Han Y; Park HC; Ahn YC
Gynecol Oncol; 2007 Nov; 107(2):320-5. PubMed ID: 17675222
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix.
Mayr NA; Magnotta VA; Ehrhardt JC; Wheeler JA; Sorosky JI; Wen BC; Davis CS; Pelsang RE; Anderson B; Doornbos JF; Hussey DH; Yuh WT
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):915-24. PubMed ID: 8751400
[TBL] [Abstract][Full Text] [Related]
6. Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer.
Mayr NA; Yuh WT; Jajoura D; Wang JZ; Lo SS; Montebello JF; Porter K; Zhang D; McMeekin DS; Buatti JM
Cancer; 2010 Feb; 116(4):903-12. PubMed ID: 20052727
[TBL] [Abstract][Full Text] [Related]
7. Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.
Mayr NA; Huang Z; Wang JZ; Lo SS; Fan JM; Grecula JC; Sammet S; Sammet CL; Jia G; Zhang J; Knopp MV; Yuh WT
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):972-9. PubMed ID: 22208967
[TBL] [Abstract][Full Text] [Related]
8. Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer.
Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Sorosky JI; Magnotta VA; Pelsang RE; Hussey DH
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):395-404. PubMed ID: 9308943
[TBL] [Abstract][Full Text] [Related]
9. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.
Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Magnotta VA; Sorosky JI; Pelsang RE; Oberley LW; Hussey DH
AJR Am J Roentgenol; 1998 Jan; 170(1):177-82. PubMed ID: 9423627
[TBL] [Abstract][Full Text] [Related]
10. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay.
Mayr NA; Yuh WT; Magnotta VA; Ehrhardt JC; Wheeler JA; Sorosky JI; Davis CS; Wen BC; Martin DD; Pelsang RE; Buller RE; Oberley LW; Mellenberg DE; Hussey DH
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):623-33. PubMed ID: 8948347
[TBL] [Abstract][Full Text] [Related]
11. Identifying the survival subtypes of glioblastoma by quantitative volumetric analysis of MRI.
Zhang Z; Jiang H; Chen X; Bai J; Cui Y; Ren X; Chen X; Wang J; Zeng W; Lin S
J Neurooncol; 2014 Aug; 119(1):207-14. PubMed ID: 24828264
[TBL] [Abstract][Full Text] [Related]
12. Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response.
Mayr NA; Yuh WT; Taoka T; Wang JZ; Wu DH; Montebello JF; Meeks SL; Paulino AC; Magnotta VA; Adli M; Sorosky JI; Knopp MV; Buatti JM
AJR Am J Roentgenol; 2006 Jul; 187(1):65-72. PubMed ID: 16794157
[TBL] [Abstract][Full Text] [Related]
13. Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01.
Lee JH; Lee SW; Kim JR; Kim YS; Yoon MS; Jeong S; Kim JH; Lee JY; Eom KY; Jeong BK; Lee SH
Gynecol Oncol; 2017 Dec; 147(3):577-584. PubMed ID: 29110878
[TBL] [Abstract][Full Text] [Related]
14. Consecutive magnetic resonance imaging during brachytherapy for cervical carcinoma: predictive value of volume measurements with respect to persistent disease and prognosis.
Mongula JE; Slangen BF; Lambregts DM; Cellini F; Bakers FC; Lutgens LC; Van Gorp T; Kruse AJ; Kruitwagen RF; Beets-Tan RG
Radiat Oncol; 2015 Dec; 10():252. PubMed ID: 26642877
[TBL] [Abstract][Full Text] [Related]
15. Can MRI predict local control rate of uterine cervical cancer immediately after radiation therapy?
Saida T; Tanaka YO; Ohara K; Oki A; Sato T; Yoshikawa H; Minami M
Magn Reson Med Sci; 2010; 9(3):141-8. PubMed ID: 20885087
[TBL] [Abstract][Full Text] [Related]
16. Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery-the "PRICE" study 2: role of conventional and DW-MRI.
Gui B; Miccò M; Valentini AL; Cambi F; Pasciuto T; Testa A; Autorino R; Zannoni GF; Rufini V; Gambacorta MA; Giordano A; Scambia G; Manfredi R
Eur Radiol; 2019 Apr; 29(4):2045-2057. PubMed ID: 30324389
[TBL] [Abstract][Full Text] [Related]
17. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of post-radiation serum squamous cell carcinoma antigen and primary tumor regression for cervical squamous cell carcinoma.
Wan Q; Yan W; Liu Y; Lin Y; Lu Z
Cancer Biomark; 2020; 29(3):327-335. PubMed ID: 32716344
[TBL] [Abstract][Full Text] [Related]
19. Early alteration in apparent diffusion coefficient and tumor volume in cervical cancer treated with chemoradiotherapy or radiotherapy: Incremental prognostic value over pretreatment assessments.
Watanabe Y; Nakamura S; Ichikawa Y; Ii N; Kawamura T; Kondo E; Ikeda T; Nomoto Y; Sakuma H
Radiother Oncol; 2021 Feb; 155():3-9. PubMed ID: 33039422
[TBL] [Abstract][Full Text] [Related]
20. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
Bowen SR; Yuh WTC; Hippe DS; Wu W; Partridge SC; Elias S; Jia G; Huang Z; Sandison GA; Nelson D; Knopp MV; Lo SS; Kinahan PE; Mayr NA
J Magn Reson Imaging; 2018 May; 47(5):1388-1396. PubMed ID: 29044908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
